| Literature DB >> 24939394 |
Bixia Ke, Jiufeng Sun, Dongmei He, Xiaocui Li, Zhaoming Liang, Chang-wen Ke1.
Abstract
BACKGROUND: Salmonella enterica includes the major serovars associated with human salmonellosis. In this study, 1764 clinical Salmonella enterica isolates from diarrhea outpatients were collected from fifteen cities in Guangdong province, China, between 2007 and 2012. These isolates represent all of the Salmonella isolates collected from the province during that period.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24939394 PMCID: PMC4071211 DOI: 10.1186/1471-2334-14-338
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Figure 1Locations where clinical diarrhea outpatients collected in Guangdong Province (marked with green color). The 15 isolation sites are marked in red and black dots in Guangdong Province, China. International borders and location of Guangdong province are also shown in the figure.
Distribution of the predominant serovars of 1764 isolates from humans with infections in Guangdong Province, China from 2007 to 2012
| Enteritidis | 14 | 17 | 28 | 31 | 48 | 119 | 257 | 14.57 |
| Typhimurium | 8 | 20 | 40 | 129 | 110 | 216 | 523 | 29.65 |
| 1,4,5,12:i:- | 0 | 6 | 4 | 16 | 79 | 139 | 244 | 13.83 |
| Stanley | 3 | 5 | 14 | 14 | 38 | 93 | 167 | 9.47 |
| Derby | 2 | 3 | 2 | 7 | 9 | 23 | 46 | 2.61 |
| Rissen | 0 | 0 | 0 | 0 | 12 | 24 | 36 | 2.04 |
| Weltevreden | 0 | 0 | 2 | 9 | 7 | 17 | 35 | 1.98 |
| Infantis | 0 | 0 | 3 | 4 | 12 | 9 | 28 | 1.58 |
| Agona | 1 | 2 | 4 | 0 | 3 | 14 | 24 | 1.36 |
| Albany | 0 | 1 | 1 | 5 | 6 | 9 | 22 | 1.25 |
| Newport | 1 | 0 | 3 | 6 | 0 | 9 | 19 | 1.08 |
| Typhi | 0 | 0 | 1 | 1 | 1 | 1 | 4 | 0.23 |
| Paratyphi(A + B + C) | 1 (B) | 0 | 3(B) | 5(2A + 2B + 1C) | 3(B) | 12(3A + 9B) | 24 | 1.36 |
| other 114 NTS serovars | 23 | 14 | 26 | 54 | 61 | 158 | 335 | 18.99 |
| Total | 53 | 68 | 131 | 281 | 389 | 843 | 1764 | 100 |
Figure 2The proportion of top 5 serovars among the total isolates from 2007 to 2012. Each data point means the proportion of each serovar in the present year (indicated as percentage in Y-axis), different serovars are indicated using different symbols as illustrated in figure.
Figure 3The prevalence of top 5 serovars among the total isolates within different age groups. Less than one years old (<1): newborn baby group; between 1 and 6 years old (1–6): Infants group; between 7 and 15 years old (7–14): juvenile; between 15 and 64 years old (7–14): adults group; more than 65 years old (>65): elderly group. The “▲” mark the predominant serovar in less than 6 years old group, and “♦” indicate the most prevalent serovar in adults.
Antimicrobial susceptibility among 1764 isolates from humans with infections in Guangdong province, China, during 2007 and 2012, and MDR in each of the top 11 serovars
| | | | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enteritidis | 257 | 143(55.64) | 11(4.28) | 14(5.45) | 18(7.01) | 212(82.49) | 11(4.28) | 141(54.86) | 23(89.49) | 76(29.57) | 23(8.95) | 110(42.81) | 10(3.89) | 116(45.14) |
| Typhimurium | 523 | 453(86.62) | 43(82.21) | 68(13.01) | 69(13.19) | 437(83.56) | 60(11.47) | 455(86.99) | 337(64.44) | 457(87.38) | 340(65.01) | 391(74.76) | 381(72.85) | 454(86.80) |
| 1,4,5,12:i:- | 244 | 220(90.16) | 18(7.37) | 30(12.29) | 29(11.88) | 182(74.59) | 28(11.47) | 220(90.16) | 128(52.46) | 228(93.44) | 141(57.78) | 164(67.21) | 164(67.21) | 218(89.34) |
| Stanley | 167 | 14(8.38) | 10(5.99) | 11(6.58) | 9(5.39) | 19(11.37) | 8(4.79) | 35(20.96) | 14(8.38) | 20(11.98) | 13(7.78) | 25(14.97) | 13(7.78) | 18(10.78) |
| Derby | 46 | 15(26.08) | 2(4.35) | 3(6.52) | 3(6.52) | 17(36.96) | 4(8.69) | 35(76.08) | 14(30.44) | 22(47.83) | 14(30.44) | 19(41.30) | 16(34.78) | 15(32.61) |
| Rissen | 36 | 26(72.22) | 3(8.33) | 5(13.89) | 6(16.67) | 5(13.89) | 1(2.78) | 23(63.89) | 30(83.33) | 31(86.11) | 7(19.44) | 16(44.44) | 5(13.89) | 15(41.67) |
| Weltevreden | 35 | 3(8.57) | 2(5.71) | 2(5.71) | 2(5.71) | 4(11.43) | 1(2.86) | 8(22.86) | 4(11.43) | 6(17.14) | 3(8.57) | 6(17.14) | 2(5.71) | 3(8.57) |
| Infantis | 28 | 23(82.14) | 0 | 3(10.71) | 2(7.14) | 23(82.14) | 0 | 23(82.14) | 19(67.86) | 19(67.86) | 4(14.28) | 4(14.28) | 21(75) | 21(75) |
| Agona | 24 | 4(16.67) | 0 | 1(4.17) | 3(12.5) | 4(16.67) | 3(12.5) | 7(29.17) | 3(12.5) | 8(33.33) | 4(16.67) | 5(20.83) | 5(20.83) | 6(25) |
| Albany | 22 | 21(95.45) | 3(13.63) | 4(18.18) | 4(18.18) | 20(90.9) | 1(4.54) | 22(100) | 20(90.9) | 21(95.45) | 4(18.18) | 7(31.81) | 21(95.45) | 20(90.9) |
| Newport | 19 | 3(15.79) | 2(10.53) | 1(5.26) | 0 | 4(21.05) | 1(5.26) | 5(26.31) | 3(15.79) | 6(31.57) | 2(10.53) | 5(26.31) | 3(15.79) | 4(21.05) |
| Typhi | 4 | 1(25) | 0 | 1(25) | 0 | 1(25) | 0 | 1(25) | 1(25) | 1(25) | 1(25) | 1(25) | 1(25) | 1(25) |
| Paratyphi (A + B + C) | 24 | 5(20.83) | 2(8.33) | 1(4.16) | 1(4.16) | 5(20.83) | 1(4.16) | 4(16.66) | 0 | 2(8.33) | 1(4.16) | 4(16.66) | 0 | 3(12.5) |
| Other 114 NTS serovars | 335 | 106(31.64) | 28(8.35) | 32(9.55) | 23(6.86) | 119(35.52) | 23(6.86) | 141(42.09) | 106(31.06) | 161(31.64) | 54(16.11) | 121(36.11) | 72(21.49) | 103(30.74) |
| Total (% resistance)b | 1037(58.78) | 124(7.03) | 176(9.98) | 169(9.58) | 1052(59.64) | 142(8.05) | 1120(63.49) | 702(39.79) | 1058(59.97) | 611(34.64) | 878(49.77) | 714(40.48) | 997(56.52) | |
aThe percentage means the proportion of MDR isolates within each serotype.
bThe percentage means the proportion of MDR isolates in total 1764 isolates.
Figure 4The ratio of resistant isolates in 2007 vs 2012 (A), and the association of MDR isolates within top 5 serovars with time (B) and age (C). The red arrows showed the dramatic upgoing of the proportion of resistant isolates among total isolates (A). In panel B and C, Each data point means the proportion of MDR isolates in the present year, different serovar are indicated using different symbols as illustrated in figure.
The association analysis among predominant PFGE patterns in each serovar, MDR, age and geography location
| Number of PFGE pattern (n) | 286(n = 702)a | 78(n = 232) | 72(n = 150) | 24(n = 28) | 53(n = 77) |
| Predominant PFGE pattern (n, %)b | JPXX01.GD0004 | JEGX01.GD0006 | JNGX01.GD0006 | None | None |
| (n = 150, 21.37%) | (n = 50, 21.55%) | (n = 23, 15.33%) | |||
| JEGX01.GD0007 | JNGX01.GD0007 | ||||
| (n = 50, 21.55%) | (n = 29, 19.33%) | ||||
| Age ≤ 6 years | 141 | 51 | 44 | | |
| >6 years | 9 | 49 | 8 | ||
| Location | Dongguan | Dongguan | Dongguan | | |
| Foshan | Foshan | Foshan | |||
| Guangzhou | Guangzhou | Guangzhou | |||
| Jiangmen | Heyuan | Jieyang | |||
| Jieyang | Huizhou | Maoming | |||
| Maoming | Jiangmen | Zhanjiang | |||
| Shantou | Jieyang | Zhaoqing | |||
| Yangjiang | Maoming | Zhongshan | |||
| Zhaoqing | Shaoguan | Zhuhai | |||
| Zhongshan | Yangjiang | ||||
| Zhuhai | Zhongshan | ||||
| Zhuhai | |||||
| MDR pattern (n, %)c | ACSSuT (99, 66.00%) | JEGX01.GD0006 | JNGX01.GD0006 | | |
| None | None | ||||
| JEGX01.GD0007 | JNGX01.GD0007 | ||||
| ASSuT-Nal (30, 30%) | None | ||||
| ASSu-Nal (17, 17%) |
an = number of isolates which PFGE data available.
bn = number of isolates in the predominant PFGE pattern, % = percentage in isolates with PFGE data.
cn = number of MDR isolates in the predominant PFGE pattern, % = percentage in predominant PFGE pattern isolates.